57
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
666264
Arietis is a biotechnology company focused on the discovery and development of novel antimicrobial agents.
- Mike La Fleur: CEO
- Anu Arya: Associate Director, Pharmacology
About the Company
Arietis is a biotechnology company focused on the discovery and development of novel antimicrobial agents. The company develops first-in-class small molecule antibiotics to kill drug-resistant bacterial pathogens and treat infections with a high unmet clinical need. Its drug discovery pipeline focuses on sterilizing antibiotics that target
Staphylococcus aureus, a leading cause of nosocomial and community-acquired infections, and Helicobacter pylori, a cause of gastric ulcers and cancer. A newer discovery platform involves using synthetic biology to manipulate the human gut microbiome to improve human health and cure disease.
Arietis was founded in 2006 and is based in Boston, Massachusetts.
